Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Therapeutic Drug Monitoring|August 2, 2007
Prediction of unbound mycophenolic acid concentrations in patients after hematopoietic cell transplantationJiayin Huang, Pamala Jacobson, Richard BrundageClinical Pharmacokinetics|April 15, 2004
Pharmacokinetic enhancement of protease inhibitor therapyJennifer R King, Heather Wynn, Richard Brundage, et al.Journal of Pharmacokinetics and Pharmacodynamics|July 25, 2019
Orphan drug development: the increasing role of clinical pharmacologyMariam A Ahmed, Malek Okour, Richard Brundage, et al.Pharmaceutical Research|October 5, 2013
Bayesian approach to estimate AUC, partition coefficient and drug targeting index for studies with serial sacrifice designTianli Wang, Kyle Baron, Wei Zhong, et al.Epilepsy Research|September 18, 2012
Bioavailability of intranasal vs. rectal diazepamVijay Ivaturi, Robert Kriel, Richard Brundage, et al.Journal of Clinical Pharmacology|January 14, 2011
Population pharmacokinetic and concentration--QTc models for moxifloxacin: pooled analysis of 20 thorough QT studiesJeffry A Florian, Christoffer W Tornøe, Richard Brundage, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2003
Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantationPamala A Jacobson, Juki Ng, Kathleen G E Green, et al.Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 12, 2014
Interrelationships among cortisol, 17-hydroxyprogesterone, and androstenendione exposures in the management of children with congenital adrenal hyperplasiaKyriakie Sarafoglou, Cheryl L Zimmerman, Maria T Gonzalez-Bolanos, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 16, 2007
Efavirenz pharmacokinetics in HIV-1-infected children are associated with CYP2B6-G516T polymorphismAkihiko Saitoh, Courtney V Fletcher, Richard Brundage, et al.Journal of Clinical Pharmacology|November 12, 2014
Comparison of cortisol exposures and pharmacodynamic adrenal steroid responses to hydrocortisone suspension vs. commercial tabletsKyriakie Sarafoglou, Maria T Gonzalez-Bolanos, Cheryl L Zimmerman, et al.Pageof 3